{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"1"}],"units":"Participants"}],"description":"Number of participants with at least 4 fold increase in absolute CD3-CD56+ NK cell count/uL blood 7 days after infusion over the pre-study baseline level","groups":[{"description":"Expanded Natural Killer Cell Infusion\n\nENK Cell Infusion: Day 0(1 dose) ENK Cell Infusion Day 0 to + 12 (13 doses) Aldesleukin (IL2), 3x10 IU","id":"OG000","title":"ENK Cell Infusion"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"7 days","title":"Increase in ENK (Expanded Natural Killer Cells) Cells 7 Days After Treatment","type":"PRIMARY","unitOfMeasure":"Participants"}